36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds

CompletedOBSERVATIONAL
Enrollment

1,421

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
MeningitisMeningococcal Disease
Interventions
BIOLOGICAL

None administered in this study

N/A in this study

Trial Locations (1)

94612

Oakland

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00728260 - 36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds | Biotech Hunter | Biotech Hunter